Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peretinoin for Recurrence Suppression in HCV-Positive HCC
NCT01640808Phase 3Completed
- Sponsor
- Kowa Company, Ltd.
- Start
- Apr 2012
- Primary completion
- Oct 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of peretinoin in hepatocellular carcinoma (HCC), sponsored by Kowa Company, Ltd.. Started Apr 2012; status: completed.
02
Drugs
peretinoin
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT01640808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01640808.